1. In the last paragraph of 'Effects of FPR2 agonists on macrophage polarization' in the 'Results' section: After the sentence 'To further confirm these results, we then compared the mRNA expression levels of these phenotypes in tumor-infiltrating macrophages (TIMs) from in situ tumor tissue using real-time PCR (Supplementary Figure S2 )' add one sentence 'As CXCL8 is not expressed in mouse, we detected another TAM phenotype TGF-b1 instead.' and the related reference 'Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye ZY, Tao HQ et al. (2011) . Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer. Cancer Sci 102: 336-342.' 2. The two sentences of the above same paragraph: 'Consistent with the in vitro study, the macrophages in the H22 group showed an M2d-like profile (high levels of IL-10, IL-23p19, IL-6, IL-1b, TNFa, CCL17, CCL1 and CXCL8; low expressions of IL-12p35 and CXCL13)' and 'IL-23p19, IL-6, IL-1b, TNFa, CCL1 and CXCL8 were inhibited by ANXA1' Replace 'CXCL8' with 'TGF-b1'.
3. In the last sentence of 'STAT3 phosphorylation is responsible for FPR2-mediated M2 subset differentiation' in the 'Results' section: 'however, it was not M-CSF þ involved in the FPR2 agonist SAA-mediated CCL1 secretion.' Delete 'M-CSF þ '.
4. In Figure 6b , 'CXCL18' should be replaced by 'CXCL8'. The modified Figure 6 is shown below. Figure S2C , change 'CXCL8' to 'TGF-b1'. We were previously confused and used the human data of CXCL8. We apologize for that. Mouse does not have CXCL8. We have now provided the modified Figure S2 .
RETRACTION
Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control The authors wish to retract this article after examination of the publication raised concerns that the primary real-time PCR data, which underlie several of the figures in the article, may not be accurate. The integrity of all of the data presented therefore cannot be assured.
